Female Viagra – FDA Backed Flibanserin Works By Boosting Women’s Psychological Desire For Sex, But It Has A Dark Past

The U.S. Food and Drug Administration (FDA) has backed an experimental drug, but Flibanserin hasn’t had a stellar run so far.

Touted as the Female Viagra, Flibanserin has been supported by the FDA Advisory Panel that voted 18-6 in favor of approving the pill. However, even the panel knew better than to give a clean-chit. The FDA panel has offered a conditional approval, which mean the manufacturer has to offer a plan to “limit its safety risks.” The female pill has been voted against twice earlier, and hence it is unclear how the makers could convince FDA this time.

Unlike regular Viagra, which helps men sustain an erection for longer periods of time by redirecting blood to the genitalia, Flibanserin apparently works on a more psychological level. The drug is said to help boost a woman’s psychological desire for sex. What this means in the real world is that the blue-pill for women has to be taken daily and over time, can affect the levels of certain chemicals in the brain, which allows women to have “sexually satisfying intercourse.”

What’s concerning is that the drug has had a lot of undesired side-effects. During the clinical trials, 14 percent of the women dropped out since they were said to have experienced dizziness and sleepiness. Worryingly, the clinical trials reaffirmed the risks by indicating a female taking Flibanserin has 10 times the risk of dizziness and four times the risk of sleepiness.

A perfectly working female Viagra could open a whole new market. Incidentally, Viagra may work, but blood-flow to the genitals does nothing to women or their ability to have a fun-filled intercourse. Pfizer, the makers of Viagra learnt the lesson the hard way, when they attempted to market regular Viagra to women. Though Viagra did increase blood flow, it didn’t have any effect on women’s desire for sex.

From a nuero-biological perspective, Flibanserin is an ideal candidate. The drug targets two neurotransmitters in the brain that can help inspire sexual desire. The first is dopamine which control’s the brain’s reward and pleasure centers. The second is norepinephrine, which controls our attention and willingness to respond to external stimuli.

It is has been quite obvious that sex as a subject greatly varies in the genders. Males, it turns out, are quite simple, but women need a lot of factors going on for them. If the makers of Flibanserin are able to limit the adverse side-effects, they could truly earn the admiration and appreciation not only from the female population, but the men too, as the drug would allow women to enjoy sex and not moan about it.

[Image Credit | Ulrich Baumgarten / Getty Images]